Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathy

Current Eye Research

Volumn 28, Issue 4, 2004, Pages 291-295

  Taban, Mehryar ^a   Thomas, Edgar L ^a,b   Boyer, David S ^a   Novack, Roger L ^a   Chu, Thomas G ^a   Gallemore, Ron P ^a  

^a RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^b NONE   (United States)

Author keywords

Choroidal neovascularization; Diabetic retinopathy; Laser photocoagulation; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CHOROID; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC MICROVASCULOPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER; LASER COAGULATION; MALE; MICROANEURYSM; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION;

AGED; CHOROIDAL NEOVASCULARIZATION; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES;

EID: 1842833443     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.4.291.27829     Document Type: Article

References (28)

1. Sickenberg M, Schmidt-Erfurth U, Miller JW. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000;118:327-336.
2. Shah GK, Sharma S, Brown GC. Choroidal neovascularization following argon laser photocoagulation for macular edema associated with branch retinal vein obstruction. Can J Ophthalmol. 2000;35:427-430.
3. Guyer DR, D'Amico DJ, Smith CW. Sub-retinal fibrosis after laser photocoagulation for diabetic macular edema. Am J Ophthalmol. 1992;113:652-656.
4. Lewis H, Schachat AP, Haimann MH et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema Ophthalmol. 1990;97:503-511.
5. Chandra SR, Bresnick GH, Davis MD et al. Choriovitreal neovascular ingrowth after photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol. 1980;98: 1593-1599.
6. Varley MP, Frank E, Purnell EW. Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology. 1988;95:567-573.
7. Schatz H, Yannuzzi LA, Gitter KA. Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: Complication or misdiagnosis? Trans Am Acad Ophthalmol Otolaryngol. 1977;83:893-906.
8. Ha TW, Ham D, Kang SW. Management of choroidal neovascularization following laser photocoagulation for central serous chorioretinopathy. Korean J Ophthalmol. 2002;16: 88-92.
9. Thomas EL, Apple DJ, Swartz M et al. Histopathology and ultrastructure of krypton and argon laser lesions in a human retina-choroid. Retina. 1984;4:22-39.
10. Peyman GA, Raichand M, Zeimer RC. Ocular effects of various laser wavelengths. Surv Ophthalmol. 1984;28:391-404.
11. Shah GK. Photodynamic therapy for choroidal neovascularization after thermal laser photocoagulation for diabetic macular edema. Am J Ophthalmol. 2003;135:114-116.
12. Ladd BS, Solomon SD, Bressler NM et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Am J Ophthalmol. 2001;132:659-667.
13. Woodburn KW, Engelman CJ, Blumenkranz MS. Photodynamic therapy for choroidal neovascularization. Retina. 2002;22:391-405.
14. Early treatment diabetic retinopathy study research group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol. 1985;103:1796-1806.
15. Schmidt-Erfurth U, Miller JW, Sickenberg M et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of re-treatments in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1177-1187.
16. Miller JW, Schmidt-Erfurth U, Sickenberg M et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1161-1173.
17. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
18. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina. 2002;22:6-18.
19. Ryan SJ. Sub-retinal neovascularization after argon laser photocoagulation. Albrecht von Graefes Arch Klin Exp Ophthalmol. 1980;215:29-42.
20. Ishibashi T, Miller H, Orr G et al. Morphologic observations on experimental sub-retinal neovascularization in the monkey. Invest Ophthalmol Vis Sci. 1987;28:1116-1130.
21. Schmidt-Erfurth U, Miller J, Sickenberg M et al. Photodynamic therapy of sub-foveal choroidal neovascularization: Clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998;236:365-374.
22. Rosenfeld PJ. Ocular photodynamic therapy with verteporfin: Clinical trial results and current indications for treatment. Focal Points. American Academy of Ophthalmology. 2002:1-17.
23. Wang LK, Kansal S, Pulido JS. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Am J Ophthalmol. 2002;134: 790-792.
24. Eandi CM, Piccolino FC, Ventre L et al. Photodynamic therapy for choroidal neovascularization in eyes with retinal vascular disorders. Retina. 2002;22:495-498.
25. Schmidt-Erfurth U, Michels S, Kusserow C et al. Photodynamic therapy for symptomatic choroidal hemangiomas: visual and anatomic results. Ophthalmology. 2002; 109:2284-2294.
26. Fernandez-Blanco TC, Olivan PS, Novella FE et al. Photodynamic therapy for choroidal neovascularization not caused by age related macular degeneration or pathologic myopia. Arch Soc Esp Oftalmol. 2003;78:471-476.
27. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of sub-foveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol. 1999;117:1329-1345.
28. Margherio RR, Margherio AR, DeSantis ME. Laser treatments with verteporfin therapy and its potential impact on retinal practices. Retina. 2002;20:325-330.